SAN DIEGO--(BUSINESS WIRE)-- Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise research and development software and services company, today announced that due to anticipated inclement ...

Non-GAAP Revenue up 14% to $43.4 million SAN DIEGO--(BUSINESS WIRE)-- Accelrys, Inc. (NASDAQ: ACCL) today reported financial results for the fiscal quarter ended September 30, 2012, including a 14% ...

Is Accelrys, Inc. (NASDAQ:ACCL) worth your attention right now? The smart money is taking an optimistic view. The number of bullish hedge fund positions increased by 1 lately. In the eyes of most ...

Freeslate expands rights for Lab Execution and Analysis (LEA) software. Sunnyvale, CA and San Diego, CA (PRWEB) April 18, 2013 Freeslate, Inc., the leading provider of high throughput research systems ...

SAN FRANCISCO (MarketWatch) -- Accelrys Inc. ACCL, +14.83% said late Thursday it will be unable to file its 10-Q for the third quarter ended Dec. 31, 2005, on time due to ongoing discussions with the ...

SAN DIEGO-- (BUSINESS WIRE)--Accelrys, Inc. (NASDAQ: ACCL), a leading scientific enterprise research and development software and services company, today announced that it has acquired privately-held ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Located in San Diego, California, Accelrys is a leading scientific enterprise R&D software and services company ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Accelrys, Inc., a leading scientific enterprise R&D software and services company, today announced it has ...

Accelrys, Inc. ACCL, a leading provider of scientific innovation lifecycle management software, is solidifying its market leadership in the laboratory informatics space with the acquisition of its ...

ACCELRYS, INC. No price found Investor Larry Richard Ferguson owns 8,844 units of Restricted stock units. Larry Richard Ferguson used to own units in Common stock but no longer holds any shares ...

With the results exhibited by the aforementioned studies, everyday investors must always pay attention to hedge fund and insider trading activity, and Accelrys, Inc. (NASDAQ:ACCL) is no exception.